191 related articles for article (PubMed ID: 24282341)
1. High intensity focused ultrasound, liver disease and bridging therapy.
Mearini L
World J Gastroenterol; 2013 Nov; 19(43):7494-9. PubMed ID: 24282341
[TBL] [Abstract][Full Text] [Related]
2. High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients.
Cheung TT; Fan ST; Chan SC; Chok KS; Chu FS; Jenkins CR; Lo RC; Fung JY; Chan AC; Sharr WW; Tsang SH; Dai WC; Poon RT; Lo CM
World J Gastroenterol; 2013 May; 19(20):3083-9. PubMed ID: 23716988
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation.
Chok KS; Cheung TT; Lo RC; Chu FS; Tsang SH; Chan AC; Sharr WW; Fung JY; Dai WC; Chan SC; Fan ST; Lo CM
Liver Transpl; 2014 Aug; 20(8):912-21. PubMed ID: 24753206
[TBL] [Abstract][Full Text] [Related]
4. Developments in liver transplantation for hepatocellular carcinoma.
Melloul E; Lesurtel M; Carr BI; Clavien PA
Semin Oncol; 2012 Aug; 39(4):510-21. PubMed ID: 22846868
[TBL] [Abstract][Full Text] [Related]
5. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
6. Bridging to liver transplantation in HCC patients.
Kollmann D; Selzner N; Selzner M
Langenbecks Arch Surg; 2017 Sep; 402(6):863-871. PubMed ID: 28755240
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: interventional bridging to liver transplantation.
Lubienski A
Transplantation; 2005 Sep; 80(1 Suppl):S113-9. PubMed ID: 16286887
[TBL] [Abstract][Full Text] [Related]
8. High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantation.
Cheung TT; Chok KS; Lo RC; Sharr WW; Chan SC; Poon RT; Fan ST; Lo CM
Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):542-4. PubMed ID: 23060402
[TBL] [Abstract][Full Text] [Related]
9. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
[TBL] [Abstract][Full Text] [Related]
10. Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant.
Wong TC; Lee VH; Law AL; Pang HH; Lam KO; Lau V; Cui TY; Fong AS; Lee SW; Wong EC; Dai JW; Chan AC; Cheung TT; Fung JY; Yeung RM; Luk MY; Leung TW; Lo CM
Hepatology; 2021 Nov; 74(5):2580-2594. PubMed ID: 34091914
[TBL] [Abstract][Full Text] [Related]
11. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
[TBL] [Abstract][Full Text] [Related]
12. Multimodal treatment strategies in patients undergoing surgery for hepatocellular carcinoma.
Lurje G; Lesurtel M; Clavien PA
Dig Dis; 2013; 31(1):112-7. PubMed ID: 23797132
[TBL] [Abstract][Full Text] [Related]
13. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
15. Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma.
Cheung TT; Chu FS; Jenkins CR; Tsang DS; Chok KS; Chan AC; Yau TC; Chan SC; Poon RT; Lo CM; Fan ST
World J Surg; 2012 Oct; 36(10):2420-7. PubMed ID: 22699746
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
[TBL] [Abstract][Full Text] [Related]
17. Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma.
Cheung TT; Fan ST; Chu FS; Jenkins CR; Chok KS; Tsang SH; Dai WC; Chan AC; Chan SC; Yau TC; Poon RT; Lo CM
HPB (Oxford); 2013 Aug; 15(8):567-73. PubMed ID: 23458602
[TBL] [Abstract][Full Text] [Related]
18. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future).
Ishizaki Y; Kawasaki S
J Gastroenterol; 2008; 43(1):18-26. PubMed ID: 18297431
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for hepatocellular carcinoma in Singapore.
Wai CT; Lee YM; Wang SC; Da Costa M; Isaac J; Wee A; Lim SG
Singapore Med J; 2006 Jul; 47(7):584-7. PubMed ID: 16810428
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
